HEADER METAL BINDING PROTEIN 03-JUL-14 2MRD TITLE SOLUTION STRUCTURE OF HUMAN CA2+-LOADED S100A4 CYS-FREE MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN S100-A4; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CALVASCULIN, METASTASIN, PLACENTAL CALCIUM-BINDING PROTEIN, COMPND 5 PROTEIN MTS1, S100 CALCIUM-BINDING PROTEIN A4; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: S100A4, CAPL, MTS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET21A KEYWDS S100A4, CALCIUM-BINDING, METAL BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.C.CHO,K.W.HUNG,C.YU REVDAT 2 14-JUN-23 2MRD 1 REMARK SEQADV REVDAT 1 08-JUL-15 2MRD 0 JRNL AUTH C.C.CHO,K.W.HUNG,D.R.GORJA,C.YU JRNL TITL THE SOLUTION STRUCTURE OF HUMAN CALCIUM-BOUND S100A4 MUTATED JRNL TITL 2 AT FOUR CYSTEINE LOCI JRNL REF J.BIOMOL.NMR V. 62 233 2015 JRNL REFN ISSN 0925-2738 JRNL PMID 25855140 JRNL DOI 10.1007/S10858-015-9927-6 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA, ARIA REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES (ARIA), LINGE, REMARK 3 O'DONOGHUE AND NILGES (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MRD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000103960. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6 REMARK 210 IONIC STRENGTH : 0.02 REMARK 210 PRESSURE : AMBIENT ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 13C; U-100% 15N] REMARK 210 S100A4-1, 16 MM TRIS-2, 8 MM REMARK 210 SODIUM CHLORIDE-3, 6 MM CALCIUM REMARK 210 CHLORIDE-4, 0.1 MM EDTA-5, 0.34 REMARK 210 MM SODIUM AZIDE-6, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCACB; 3D CBCA(CO) REMARK 210 NH; 3D HN(CA)CO; 3D HNCO; 3D REMARK 210 C(CO)NH; 3D H(CCO)NH; 3D HBHA(CO) REMARK 210 NH; 3D HCCH-TOCSY; 3D 1H-15N REMARK 210 NOESY; 3D 1H-13C NOESY; 3D 13C REMARK 210 F1-FILTERED, F3-EDITED NOESY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : VNMRS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMRJ, SPARKY REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 -161.43 169.96 REMARK 500 1 SER A 3 -166.11 -41.50 REMARK 500 1 PRO A 4 -17.44 -29.93 REMARK 500 1 ARG A 49 82.28 -165.67 REMARK 500 1 THR A 50 48.66 -93.34 REMARK 500 1 ASP A 63 79.94 -59.53 REMARK 500 1 PRO A 94 91.26 -58.69 REMARK 500 1 LYS A 100 -48.36 -166.88 REMARK 500 1 ALA B 2 -161.37 169.86 REMARK 500 1 SER B 3 -166.01 -41.56 REMARK 500 1 PRO B 4 -17.56 -29.90 REMARK 500 1 ARG B 49 82.37 -165.97 REMARK 500 1 THR B 50 49.00 -93.54 REMARK 500 1 ASP B 63 79.87 -59.51 REMARK 500 1 PRO B 94 91.25 -58.76 REMARK 500 1 LYS B 100 -48.34 -167.43 REMARK 500 2 ALA A 2 43.30 -86.03 REMARK 500 2 SER A 3 -154.26 -27.76 REMARK 500 2 PRO A 4 -13.64 -29.57 REMARK 500 2 ARG A 49 80.63 -155.48 REMARK 500 2 ASP A 63 80.89 -66.00 REMARK 500 2 ARG A 99 -38.34 71.05 REMARK 500 2 ALA B 2 43.42 -86.08 REMARK 500 2 SER B 3 -154.23 -27.58 REMARK 500 2 PRO B 4 -13.82 -29.59 REMARK 500 2 ARG B 49 80.70 -155.43 REMARK 500 2 ASP B 63 80.71 -66.18 REMARK 500 2 ARG B 99 -37.88 70.85 REMARK 500 3 ALA A 2 39.15 -83.40 REMARK 500 3 SER A 3 159.12 -43.15 REMARK 500 3 PRO A 4 -6.75 -14.81 REMARK 500 3 ARG A 49 73.98 -152.45 REMARK 500 3 ASP A 51 146.94 -171.45 REMARK 500 3 ASP A 63 81.38 -58.38 REMARK 500 3 LYS A 100 -50.73 -167.85 REMARK 500 3 ALA B 2 39.41 -83.18 REMARK 500 3 SER B 3 159.14 -43.60 REMARK 500 3 PRO B 4 -6.77 -14.91 REMARK 500 3 ARG B 49 73.89 -152.52 REMARK 500 3 ASP B 51 146.97 -172.19 REMARK 500 3 ASP B 63 81.81 -58.52 REMARK 500 3 LYS B 100 -51.32 -167.79 REMARK 500 4 SER A 3 -161.91 -40.36 REMARK 500 4 PRO A 4 -13.94 -31.48 REMARK 500 4 LYS A 26 -4.87 -142.24 REMARK 500 4 ARG A 49 71.16 -164.74 REMARK 500 4 ASP A 63 83.49 -66.64 REMARK 500 4 PRO A 94 94.69 -58.51 REMARK 500 4 LYS A 100 -51.94 -164.22 REMARK 500 4 SER B 3 -161.94 -40.29 REMARK 500 REMARK 500 THIS ENTRY HAS 286 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 3 PRO A 4 3 -136.18 REMARK 500 SER B 3 PRO B 4 3 -136.10 REMARK 500 SER A 3 PRO A 4 10 -133.48 REMARK 500 SER B 3 PRO B 4 10 -133.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25069 RELATED DB: BMRB DBREF 2MRD A 1 101 UNP P26447 S10A4_HUMAN 1 101 DBREF 2MRD B 1 101 UNP P26447 S10A4_HUMAN 1 101 SEQADV 2MRD SER A 3 UNP P26447 CYS 3 ENGINEERED MUTATION SEQADV 2MRD SER A 76 UNP P26447 CYS 76 ENGINEERED MUTATION SEQADV 2MRD SER A 81 UNP P26447 CYS 81 ENGINEERED MUTATION SEQADV 2MRD SER A 86 UNP P26447 CYS 86 ENGINEERED MUTATION SEQADV 2MRD SER B 3 UNP P26447 CYS 3 ENGINEERED MUTATION SEQADV 2MRD SER B 76 UNP P26447 CYS 76 ENGINEERED MUTATION SEQADV 2MRD SER B 81 UNP P26447 CYS 81 ENGINEERED MUTATION SEQADV 2MRD SER B 86 UNP P26447 CYS 86 ENGINEERED MUTATION SEQRES 1 A 101 MET ALA SER PRO LEU GLU LYS ALA LEU ASP VAL MET VAL SEQRES 2 A 101 SER THR PHE HIS LYS TYR SER GLY LYS GLU GLY ASP LYS SEQRES 3 A 101 PHE LYS LEU ASN LYS SER GLU LEU LYS GLU LEU LEU THR SEQRES 4 A 101 ARG GLU LEU PRO SER PHE LEU GLY LYS ARG THR ASP GLU SEQRES 5 A 101 ALA ALA PHE GLN LYS LEU MET SER ASN LEU ASP SER ASN SEQRES 6 A 101 ARG ASP ASN GLU VAL ASP PHE GLN GLU TYR SER VAL PHE SEQRES 7 A 101 LEU SER SER ILE ALA MET MET SER ASN GLU PHE PHE GLU SEQRES 8 A 101 GLY PHE PRO ASP LYS GLN PRO ARG LYS LYS SEQRES 1 B 101 MET ALA SER PRO LEU GLU LYS ALA LEU ASP VAL MET VAL SEQRES 2 B 101 SER THR PHE HIS LYS TYR SER GLY LYS GLU GLY ASP LYS SEQRES 3 B 101 PHE LYS LEU ASN LYS SER GLU LEU LYS GLU LEU LEU THR SEQRES 4 B 101 ARG GLU LEU PRO SER PHE LEU GLY LYS ARG THR ASP GLU SEQRES 5 B 101 ALA ALA PHE GLN LYS LEU MET SER ASN LEU ASP SER ASN SEQRES 6 B 101 ARG ASP ASN GLU VAL ASP PHE GLN GLU TYR SER VAL PHE SEQRES 7 B 101 LEU SER SER ILE ALA MET MET SER ASN GLU PHE PHE GLU SEQRES 8 B 101 GLY PHE PRO ASP LYS GLN PRO ARG LYS LYS HELIX 1 1 SER A 3 GLY A 21 1 19 HELIX 2 2 LYS A 31 LEU A 42 1 12 HELIX 3 3 ASP A 51 ASP A 63 1 13 HELIX 4 4 PHE A 72 PHE A 89 1 18 HELIX 5 5 SER B 3 GLY B 21 1 19 HELIX 6 6 LYS B 31 LEU B 42 1 12 HELIX 7 7 ASP B 51 ASP B 63 1 13 HELIX 8 8 PHE B 72 PHE B 89 1 18 SHEET 1 A 2 LYS A 28 ASN A 30 0 SHEET 2 A 2 GLU A 69 ASP A 71 -1 O VAL A 70 N LEU A 29 SHEET 1 B 2 LYS B 28 ASN B 30 0 SHEET 2 B 2 GLU B 69 ASP B 71 -1 O VAL B 70 N LEU B 29 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1